October 22, 2019
  • October 22, 2019
Breaking News

Tag Archives

FDA approved Pfizer Inc. (NYSE:PFE) oncology biosimilar Zirabev

by on June 28, 2019 0
Pfizer Inc. (NYSE:PFE) said the U.S. Food and Drug Administration has approved its oncology biosimilar Zirabev for the treatment of five types of cancer. The FDA has approved the drug to treat metastatic colorectal cancer, unresectable, locally advanced, recurrent or metastatic non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, and persistent,... Read More